MedNet Solutions Receives First Major Outside Financing
Funds to Accelerate iMedNet EDC Sales, Marketing and R&D Initiatives
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, announced that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has made a $4 million investment in MedNet Solutions. This funding will be used to support the ongoing growth and development of both MedNet and iMedNet EDC, its flagship cloud-based eClinical technology platform.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
